Monte Rosa Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $6.6M | 400k | 16.45 |
| 2023-03-31 | $23M | 2.9M | 7.79 |
| 2022-12-31 | $22M | 2.9M | 7.61 |
| 2022-09-30 | $25M | 3.0M | 8.17 |
| 2022-06-30 | $29M | 3.0M | 9.67 |
| 2022-03-31 | $42M | 3.0M | 14.02 |
| 2021-12-31 | $61M | 3.0M | 20.42 |
| 2021-09-30 | $68M | 3.1M | 21.91 |
| 2021-06-30 | $70M | 3.2M | 21.78 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management